Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
[Heart transplantation : Current situation]
1Klinik für Thorax- und Kardiovaskularchirurgie, Herz- und Diabeteszentrum NRW, Universitätsklinikum, Ruhr-Universität Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Deutschland. rschramm@hdz-nrw.de.
Insights
Heart transplantation is a vital treatment for end-stage heart failure. Donor heart shortages and post-transplant rejection are key challenges managed through allocation policies and immunosuppression.
Area of Science:
- Cardiology and Transplant Surgery
- Immunology and Pharmacology
Context:
- Heart transplantation is the definitive treatment for end-stage heart failure.
- Donor organ scarcity necessitates regulated allocation and advanced preservation techniques.
- Surgical techniques and post-operative management are critical for successful outcomes.
Purpose:
- To provide an overview of heart transplantation as a treatment modality.
- To highlight challenges in donor heart availability and allocation.
- To discuss surgical techniques, preservation, and immunosuppression strategies.
Summary:
- Heart transplantation is the gold-standard for end-stage heart failure, but donor organ shortage is a major limitation.
- The Transplantation Act governs donor heart allocation based on urgency and success probability.
- Both biatrial and bicaval techniques are used for implantation, with the latter offering fewer complications. Mechanical perfusion extends transport viability.
- Post-transplant immunosuppression is essential for preventing rejection and ensuring long-term patient survival.
Impact:
- Informs clinical practice regarding heart transplant allocation and surgical options.
- Underscores the importance of immunosuppression in managing post-transplant complications.
- Highlights areas for future research in organ preservation and donor pool expansion.
Abstract:
Heart transplantation is the gold-standard in the treatment of terminal heart failure. The shortage of donor hearts represents the major obstacle in patient care and necessitates the creation of waiting lists and allocation algorithms. The Transplantation Act regulates donor heart allocation according to the urgency and the prospects of success. Donor hearts can be implanted following the classical biatrial or the modern bicaval valve implantation technique with a slightly lower spectrum of complications. Modern mechanical perfusion systems enable extended transport times. After heart transplantation rejection reactions must be controlled by an individually adjusted immunosuppression to guarantee long-term survival with as few complications as possible.
More Related Videos
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Cardiomyopathy V: Interprofessional Care

